Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 3,262,833
  • Shares Outstanding, K 347,850
  • Annual Sales, $ 9,674 M
  • Annual Income, $ -2,409,000 K
  • 36-Month Beta -0.17
  • Price/Sales 0.33
  • Price/Cash Flow 0.66
  • Price/Book 0.99

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.31 +11.31%
on 04/24/17
11.43 -19.07%
on 03/29/17
-1.43 (-13.39%)
since 03/28/17
3-Month
8.31 +11.31%
on 04/24/17
17.14 -46.03%
on 02/16/17
-4.22 (-31.33%)
since 01/27/17
52-Week
8.31 +11.31%
on 04/24/17
38.50 -75.97%
on 05/03/16
-26.00 (-73.76%)
since 04/28/16

Most Recent Stories

More News
Bausch + Lomb Receives 510(k) Clearance From FDA For Vitesse(TM), The First And Only Hypersonic, Open-Port Vitrectomy System

First Major Vitreous Removal Advancement in 40 Years to be Available Through the New Stellaris EliteTM Vision Enhancement System

VRX.TO : 12.65 (-0.86%)
VRX : 9.25 (-1.39%)
Shares of VRX Down 64.0% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Valeant Pharmaceuticals International (NYSE:VRX) on September 30th, 2016 at $25.04. In approximately 7 months, Valeant Pharmaceuticals International has returned 64.03%...

VRX : 9.25 (-1.39%)
Blog Coverage: Valeant Announces the Pricing for SILIQ as the Lowest Priced Injectable Biologic for Moderate-To-Severe Plaque Psoriasis

Upcoming AWS Coverage on Adamis Pharmaceuticals Post-Earnings Results

VRX.TO : 12.65 (-0.86%)
ADMP : 3.70 (-5.13%)
VRX : 9.25 (-1.39%)
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ(TM) (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the company has decided...

VRX.TO : 12.65 (-0.86%)
VRX : 9.25 (-1.39%)
4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings

Here is a look at four Sell-Ranked drug stocks with negative earnings ESP that should be avoided ahead of earnings.

TECH : 107.08 (+0.43%)
DRNA : 3.33 (-1.48%)
VYGR : 10.44 (-1.51%)
JNJ : 123.47 (-0.22%)
VRX : 9.25 (-1.39%)
Watch for Valeant Pharmaceuticals International to Potentially Rebound After Falling 5.38% Yesterday

Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $8.92 to a high of $9.42. Yesterday, the shares fell 5.4%, which took the trading range below the...

VRX : 9.25 (-1.39%)
Shares of VRX Down 62.1% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Valeant Pharmaceuticals International (NYSE:VRX) on September 30th, 2016 at $25.04. In approximately 7 months, Valeant Pharmaceuticals International has returned 62.13%...

VRX : 9.25 (-1.39%)
SmarTrend Watching for Potential Rebound in Shares of Valeant Pharmaceuticals International After 1.41% Loss

Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $9.43 to a high of $9.62. Yesterday, the shares fell 1.4%, which took the trading range below the...

VRX : 9.25 (-1.39%)
Interesting VRX Put And Call Options For June 2nd

Investors in Valeant Pharmaceuticals International Inc saw new options become available today, for the June 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

VRX : 9.25 (-1.39%)
Aerie Reports Positive Data on Ophthalmic Drug Rhopressa

Aerie Pharmaceuticals, Inc. (AERI) reported encouraging six-month top-line safety and efficacy results from the phase III trial, ROCKET 4, on lead product candidate Rhopressa.

AERI : 44.05 (-1.01%)
AGN : 243.86 (+0.33%)
VRX : 9.25 (-1.39%)
PFE : 33.92 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients....

See More

Support & Resistance

2nd Resistance Point 9.60
1st Resistance Point 9.43
Last Price 9.25
1st Support Level 9.14
2nd Support Level 9.02

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.